@ApekshaNasi
iAccount based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
#Cyto #Heme @UTHealthSA_Path #IDPath Director Cytopathology MSRH San Antonio
San Antonio, TX
Joined June 2018
- Tweets2.6K
- Following1.4K
- Followers2.2K
- Likes8.1K
Liver biopsy- sinusoidal expansion by macrophages with tissue paper morphology. Macrophages positive with PAS-A stain. Gaucher disease, autosomal recessive, deficiency of glucocerebrosidase, accumulation of glucocerebroside in macrophages #surgpath #pathology #liverpath
Apeksha Ramnarayan, MD, FCAP retweeted
So honored and grateful to be selected as an @ASCP_Chicago Forty under 40 honoree! Thank you to the selection committee & Congratulations to all co honorees!
#pathtwitter If you'd like to see me in the top 5, please consider voting for me here: woobox.com/qwwo2e
Apeksha Ramnarayan, MD, FCAP retweeted
77 yo M w/ biliary stenosis. Bush #cytology during ERCP. No dysplasia, Giardia Lambdia 👻
Apeksha Ramnarayan, MD, FCAP retweeted
Who knew blueberries could teach us about healthy cells? 🫐😲. Today’s #IntroToPath, I use 'em to explain metaplasia (🖤 blackberries), hyperplasia, and hypertrophy 💪🏽. It's like a berry-licious journey through the world of pathology! 🌎#Path4People #BerriesForEducation 🍓🍒🔬
Apeksha Ramnarayan, MD, FCAP retweeted
Hi everyone! Mark your calendars for August 23, 2023 at 5:00 pm CST to learn more about our residency program at UT Health San Antonio. The link to the meeting will be shared closer to the date!
Apeksha Ramnarayan, MD, FCAP retweeted
It was a great meeting to see everyone and learn new ideas! Looking forward to many more! @KMirza @NRiddleMD @EHJPathDiva @Pathologists @DrBuiPathology @PatGodbeyMD @ApekshaNas @VaishaliPansare @CAPFndn @ahmadbelgeth @HerrPath @HansiniMD @jzhang44 @pranavp01 @AutopsyBae
This Post is from a suspended account. Learn more
Apeksha Ramnarayan, MD, FCAP retweeted
CC244. In his 40s, HIV+. FNA of a large inguinal lymph node. Be very careful, this is a TRAP. #cytopath
@DrBMcGinn @SumantaDas_7 @William28538949 @kitagawa_yukiko @gcai1978 @goziemnweke @lcasgaz95 @HubertLauMD @NHardy_path @Cristina_VargAP @FionaMacPath @pembeoltulu @atman_ci
A must read!
Clinical, pathologic & radiologic findings in SRIF @smlungpathguy @RSNA
Smoking-Related Interstitial Fibrosis (SRIF) in Patients Presenting With Diffuse Parenchymal Lung Disease | American Journal of Clinical Pathology academic.oup.com/ajcp/advanc…
Apeksha Ramnarayan, MD, FCAP retweeted
Program Director Diaries.
Protected time to learn and study is a tool for success, not a gift or charity. – at San Antonio, TX
Apeksha Ramnarayan, MD, FCAP retweeted
You are trying to explain to a resident why you think a tumor might be neuroendocrine based on H&E. What do you say?
What is the essence of “neuroendocrine morphology” in simple language?
#pathology #pulmpath
Apeksha Ramnarayan, MD, FCAP retweeted
Question template which may be asked during the residency interview.🧵
Brielfly talk about your self?
This question is your elevator pitch. Please practice & bring to the table the flash cards that demonstrate your abalities, qualities and your approach. #PathTwitter #Match2023
Apeksha Ramnarayan, MD, FCAP retweeted
With this autumn picture, I want to say that I am taking a break from social media. My Twitter account is still here in case you need to rest your eyes on some of my nature pictures. Thanks for everything! Take care.
Apeksha Ramnarayan, MD, FCAP retweeted
First weekend on call at the new job #hemepath
Apeksha Ramnarayan, MD, FCAP retweeted
Today is National Physician Suicide Awareness Day.
I am a physician who struggles with suicidal ideations.
I want to be very clear: This is not a resource problem. This is a system problem. 🧵 (1/18)
Apeksha Ramnarayan, MD, FCAP retweeted
i have edited more personal statements
this year than any other year before—
universal advice:
worry less about impressing people
WRITE MORE FROM YOUR HEART
write less commentary about specialties
write more about what you want to do
#Match2023 #PathMatch2023 #PathMatch23